UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048622
Receipt number R000042440
Scientific Title Clinical trial on the efficacy and safety for the dysuria of the mixture of Peucedanum japonicum, nobiletin and tomato lycopene
Date of disclosure of the study information 2022/08/08
Last modified on 2022/08/08 15:47:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial on the efficacy and safety for the dysuria of the mixture of Peucedanum japonicum, nobiletin and tomato lycopene

Acronym

Clinical trial for the urination disorder of the mixture of Peucedanum japonicum, nobiletin and tomato lycopene

Scientific Title

Clinical trial on the efficacy and safety for the dysuria of the mixture of Peucedanum japonicum, nobiletin and tomato lycopene

Scientific Title:Acronym

Clinical trial for the urination disorder of the mixture of Peucedanum japonicum, nobiletin and tomato lycopene

Region

Japan


Condition

Condition

Urine storage disorder (urinary frequency, nocturia, urgency, urge incontinence)

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy and safety of the peucedanum japonicum-nobiletin-tomato lycopene mixture for adult volunteers with urine storage disorders (urinary frequency, nocturia, urgency, urge incontinence).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Total score for overactive bladder symptom score

Key secondary outcomes

Daytime urinary frequency, night urinary frequency, International prostate symptom score, QOL score


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

20 active lead groups and 20 placebo lead groups

Interventions/Control_2

After 3 weeks of administration, take 2 weeks off and cross over 3 weeks of administration

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Men and women who have urinary frequency, nocturia, urgency, or urge incontinence for more than 2 months, and who have some trouble with it

Key exclusion criteria

1 micturition disorder in treatment
2 Within 2 months from the end of treatment for micturition disorder
3 have no sense of urination
4 dysuria is the main symptom
5 Communication of the will is difficult
6 Allergies to ingredients and drugs
7 Others that the doctor in charge judged that registration to this study was inappropriate

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Kimio
Middle name
Last name Sugaya

Organization

Southen Knights' Laboratory Co. Ltd.

Division name

Clinical department

Zip code

904-0113

Address

1-1-823 Miyagi, Chatan, Okinawa

TEL

090-4998-7459

Email

sugaya@med.u-ryukyu.a.jp


Public contact

Name of contact person

1st name Kimio
Middle name
Last name Sugaya

Organization

Southen Knights' Laboratory Co. Ltd.

Division name

Clinical department

Zip code

904-0113

Address

1-1-823 Miyagi, Chatan, Okinawa

TEL

090-4998-7459

Homepage URL


Email

sugaya@med.u-ryukyu.a.jp


Sponsor or person

Institute

Southen Knights' Laboratory Co. Ltd.

Institute

Department

Personal name



Funding Source

Organization

Okinawa Research Center Co. Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kawahara urology clinic Ethics Review Board

Address

73-3 Nishimotida, Ara, Kagoshima

Tel

0995-64-5181

Email

yamashita.hami@kawahara.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 08 Day


Related information

URL releasing protocol

Shinryo to Shinyaku, 2020; 57: 501-511

Publication of results

Published


Result

URL related to results and publications

Shinryo to Shinyaku, 2020; 57: 501-511

Number of participants that the trial has enrolled

40

Results

Shinryo to Shinyaku, 2020; 57: 501-511

Results date posted

2022 Year 08 Month 08 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Shinryo to Shinyaku, 2020; 57: 501-511

Participant flow

Shinryo to Shinyaku, 2020; 57: 501-511

Adverse events

Shinryo to Shinyaku, 2020; 57: 501-511

Outcome measures

Shinryo to Shinyaku, 2020; 57: 501-511

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 06 Month 05 Day

Date of IRB

2019 Year 06 Month 26 Day

Anticipated trial start date

2019 Year 09 Month 01 Day

Last follow-up date

2019 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2020 Year 05 Month 01 Day


Other

Other related information



Management information

Registered date

2022 Year 08 Month 08 Day

Last modified on

2022 Year 08 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042440


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name